Plant Biotechnology; an Important Avenue for Medicine during Pandemics
Plant Biotechnology in times of Pandemics
Keywords:
SARS-CoV-2, Pharming, plant biotechnology, in vitro cultures, transgenesis, Secondary metabolitesAbstract
The coronavirus pandemic that is still ongoing has let the world learn many lessons. One of the lessons is to search for a viable source of medicine against such viruses. Vaccines for those ailing with symptoms of such viruses are most importantly needed from a viable source. Plant biotechnology offers a platform called Biopharming,wherein vaccines are produced in a safe, biocompatible manner. These vaccines also promise to have the advantage of being produced cost-effectively once the complete map of the process is laid down and is upscaled. Vaccines are undoubtedly developed at an unprecedented rate and are the most effective strategy to fight such pandemics. However, as understood from a fundamental standpoint, the vaccine is a part of a preemptive strategy. Along with synthetic chemical compounds, phytochemicals cannot be overlooked as candidates for drugs against Severe respiratory coronavirus 2 (SARS-CoV-2). Compounds, for instance, Glycyrrhizin from the roots of Glycyrrhiza glabra have been shown as a very promising phytochemical against the SARS-CoV, which caused an outbreak in 2002-2003. Other
chemical compounds, reserpine, emodin, betulonic acid, and apigenin isolated from different plants, were also effective against SARS-CoV. The production of these and many other compounds through plant biotechnology techniques such as transgenesis and gene editing followed by in vitro cultures is a vital avenue to be considered. Transgenesis offers the advantage of boosted production of existing phytochemicals or triggered production of novel compounds through in vitro cultures which serve as a reactor for the development of important phytomedicine. This article emphasizes the role of Biopharming in the production of vaccines against SARS-CoV-2 and any such future outbreak causing Virus or bacteria. The report also highlights the role of transgenesis and gene editing to produce medicine against the Virus.
References
Worldometer. COVID-19 CORONAVIRUS PANDEMIC. (2021) Available from: https://www.worldometers.info/coronavirus/ (02 March 2021)
M. Shrotri, T. Swinnen, B. Kampmann, and E.P. Parker, An interactive website tracking COVID-19 vaccine development, The Lancet Global Health 5: e590-e592. (2021).
P. Seth, and J. Higginbotham, Advantages and disadvantages of multiple different methods of adenoviral vector construction, Hepatocellular Carcinoma. Springer. pp. 189-198.(2000).
S. Preet Kaur, and V. Gupta, COVID-19 Vaccine: A comprehensive status report, Virus Research. (2020).
C.o.D.C.a. Prevention. COVID-19 Vaccination. COVID-19 Vaccination (2021) Available from: https://www.cdc.gov/vaccines/covid-19/index.html (02 March 2021)
T. Khan, M.A. Khan, N. Ullah, and A. Nadhman, Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites, Biocatalysis and Agricultural Biotechnology: 101890. (2020).
J.G. Choi, Y.S. Kim, J.H. Kim, and H.S. Chung, Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition, Scientific reports 1: 1-12. (2019).
Z. LeBlanc, P. Waterhouse, and J. Bally, Plant-Based Vaccines: The Way Ahead?, Viruses 1: 5. (2021).
G. Walsh, Biopharmaceutical benchmarks 2018, Nature Biotechnology 12: 1136-1145. (2018).
T. Lai, Y. Yang, and S.K.J.P. Ng, Advances in mammalian cell line development technologies for recombinant protein production, Pharmaceuticals (Basel) 5: 579-603. (2013).
S. Rosales-Mendoza, Will plant-made biopharmaceuticals play a role in the fight against COVID-19?, Expert opinion on biological therapy 6: 545-548. (2020).
T. Capell, R.M. Twyman, V. Armario-Najera, J.K.-C. Ma, S. Schillberg, and P. Christou, Potential applications of plant biotechnology against SARSCoV-2, Trends in plant science 7: 635-643. (2020).
R. Fischer, and J.F. Buyel, Molecular farming–the slope of enlightenment, Biotechnology advances: 107519. (2020).
S. Miguel, E. Nisse, F. Biteau, S. Rottloff, B. Mignard, E. Gontier, A. Hehn, and F. Bourgaud, Assessing carnivorous plants for the production of recombinant proteins, Frontiers in plant science: 793. (2019).
S.-R. Kim, J.-S. Sim, H. Ajjappala, Y.-H. Kim, and B.-S. Hahn, Expression and large-scale production of the biochemically active human tissue-plasminogen activator in hairy roots of Oriental melon (Cucumis melo), Journal of bioscience and bioengineering 1: 106-111. (2012).
K.A. McDonald and R.B. Holtz, From farm to finger prick—a perspective on how plants can help in the fight against COVID-19, Frontiers in Bioengineering and Biotechnology: 782. (2020).
E.E. Hood, From green plants to industrial enzymes, Enzyme and microbial technology 3: 279-283. (2002).
M. Buntru, S. Vogel, H. Spiegel, and S. Schillberg, Tobacco BY-2 cell-free lysate: an alternative and highly-productive plant-based in vitro translation system, BMC biotechnology 1: 1-11. (2014).
A. Zimran, E. Brill-Almon, R. Chertkoff, M. Petakov, F. Blanco-Favela, E.T. Muñoz, S.E. Solorio-Meza, D. Amato, G. Duran, and F.J.B.
Giona, The Journal of the American Society of Hematology, Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease, Blood 22: 5767-5773. (2011).
M.M. Goodin, D. Zaitlin, R.A. Naidu, and S.A.J. Lommel, Nicotiana benthamiana: its history and future as a model for plant–pathogen interactions, Molecular plant-microbe interactions 8: 1015-1026. (2008).
W.E.R. Team, After Ebola in West Africa—unpredictable risks, preventable epidemics, New England Journal of Medicine 6: 587-596. (2016).
H.V. Fineberg, Pandemic preparedness and response—lessons from the H1N1 influenza of 2009, New England Journal of Medicine 14: 1335-1342. (2014).
K. Dhama, S. Natesan, M. Iqbal Yatoo, S.K. Patel, R. Tiwari, S.K. Saxena, and H. Harapan, Plant-based vaccines and antibodies to combat COVID-19: current status and prospects, Human vaccines and immunotherapeutics 12: 1-8. (2020).
K. Dhama, M.Y. Wani, R. Deb, K. Karthik, R. Tiwari, R. Barathidasan, A. Kumar, Mahima, A.K. Verma, and S.D. Singh, Plant based oral
vaccines for human and animal pathogens-a new era of prophylaxis: current and future perspectives, Journal of Experimental Biology Agricultural Sciences 1: 1-12. (2013).
P. Vermij and E. Waltz, USDA approves the first plant-based vaccine, Nature Biotechnology 3: 234. (2006).
S.J. Streatfield, J.M. Jilka, E.E. Hood, D.D. Turner, M.R. Bailey, J.M. Mayor, S.L. Woodard, K.K. Beifuss, M.E. Horn, and D.E.J.V. Delaney, Plantbased vaccines: unique advantages, Vaccine 17-19: 2742-2748. (2001).
Y. Zhang, D. Li, X. Jin, and Z. Huang, Fighting Ebola with ZMapp: spotlight on plant-made antibody, Science China. Life sciences 10: 987. (2014).
M. Paul, and J.K.C. Ma, Plant‐made pharmaceuticals: Leading products and production platforms, Biotechnology and applied biochemistry 1: 58-67. (2011).
C. Lico, L. Santi, S. Baschieri, E. Noris, C. Marusic, M. Donini, E. Pedrazzini, G. Maga, R. Franconi, and P. Di Bonito, Plant molecular farming as a strategy against COVID-19–the Italian perspective, Frontiers in plant science. (2020).
J. O’Toole, L. Robertson, and S.W. Schmid, Flu 2020.
S.R. Webb, R.M. Twyman, and M. Moloney, Agtech infrastructure for pandemic preparedness, Nature Biotechnology 9: 1025-1027. (2020).
E. Laere, A.P.K. Ling, Y.P. Wong, R.Y. Koh, M.A. Mohd Lila, and S. Hussein, Plant-Based Vaccines: Production and Challenges, Journal of Botany. (2016).
S. Naderi, and B. Fakheri, Overview of plantbased vaccines, Research Journal of Fisheries and Hydrobiology 10: 275-289. (2015).
L. Gralinski, and V. Menachery, Return of the coronavirus: 2019-nCoV., Viruses 2: 135. (2020).
A. Grifoni, J. Sidney, Y. Zhang, R.H. Scheuermann, B. Peters, and A. Sette, A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2, Cell host microbe 4: 671-680. e672. (2020).
M. Zheng, and L. Song, Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV, Cellular and molecular immunology 5: 536-538. (2020).
H.S. Mason and C.J. Arntzen, Transgenic plants as vaccine production systems, Trends in biotechnology 9: 388-392. (1995).
C. Liu, Q. Zhou, Y. Li, L.V. Garner, S.P. Watkins, L.J. Carter, J. Smoot, A.C. Gregg, A.D. Daniels, and S. Jervey, Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases, ACS Central Science. (2020).
L. Satish, A.S. Rency, B.C. Muthubharathi, S. Shamili, R. Rameshkumar, M.K. Swamy, and M. Ramesh, Transgenic plant cell cultures: a promising approach for secondary metabolite production, Natural Bio-active Compounds. Springer. pp. 79-122.(2019).
F.R. Bhuiyan, S. Howlader, T. Raihan, and M.J.F.i.M. Hasan, Plants metabolites: possibility of natural therapeutics against the COVID-19
pandemic, Front Med (Lausanne): 444. (2020).
M. Verhoeyen, S. Muir, G. Collins, A. Bovy, and R. de Vos. Increasing flavonoid levels in tomatoes by means of metabolic engineering. in Abstract at the 10th Symposium ALW-Discussion group Secondary metabolism in plant and plant cell. 2000.
J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. Doerr, Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus, The Lancet 9374: 2045-2046. (2003).
M. Wink, Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19, Diversity 5: 175. (2020).
R. Verpoorte and J. Memelink, Engineering secondary metabolite production in plants, Current opinions in biotechnology 2: 181-187. (2002).
B. Shanmugaraj, K. Rattanapisit, S. Manopwisedjaroen, A. Thitithanyanont, and W. Phoolcharoen, Monoclonal Antibodies B38 and
H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro, Frontiers in plant science: 589995. (2020).
Y. Wu, F. Wang, C. Shen, W. Peng, D. Li, C. Zhao, Z. Li, S. Li, Y. Bi, and Y.J.S. Yang, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Science 6496: 1274-1278. (2020).
K. Rattanapisit, B. Shanmugaraj, S. Manopwisedjaroen, P.B. Purwono, K. Siriwattananon, N. Khorattanakulchai, O. Hanittinan, W. Boonyayothin, A. Thitithanyanont, and D.R. Smith, Rapid production of SARSCoV-2 receptor binding domain (RBD) and spike
specific monoclonal antibody CR3022 in Nicotiana benthamiana, Scientific reports 1: 1-11. (2020).
B. Shanmugaraj, and W. Phoolcharoen, Addressing demand for recombinant biopharmaceuticals in the COVID-19 era, Asian Pacific Journal of Tropical Medicine 2: 49. (2021).
M. Yonesi, and A. Rezazadeh, Plants as a prospective source of natural anti-viral compounds and oral vaccines against COVID-19 coronavirus, Journal Issue. (2020)
A.M. Gudadappanavar, and J. Benni, An evidencebased systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario, Journal of basic clinical physiology pharmacology 6. (2020).
F. Agius, R. González-Lamothe, J.L. Caballero, J. Muñoz-Blanco, M.A. Botella, and V. Valpuesta, Engineering increased vitamin C levels in plants by overexpression of a D-galacturonic acid reductase, Nature Biotechnology 2: 177-181. (2003).
H. Jeroch, W. Drochner, and O. Simon, Ernährung landwirtschaftlicher nutztiere: Ernährungsphysiologie, futtermittelkunde,
fütterung. Vol. 8180. 2008: UTB.
S. Rochfort and J. Panozzo, Phytochemicals for health, the role of pulses, Journal of agricultural food chemistry 20: 7981-7994. (2007).
B. Prakash, Functional and Preservative Properties of Phytochemicals. 2020: Academic Press.
E.K. Arendt, and E. Zannini, Cereal grains for the food and beverage industries. 2013: Elsevier.
H. Nishino, M. Murakoshi, X.Y. Mou, S. Wada, M. Masuda, Y. Ohsaka, Y. Satomi, and K.J.O. Jinno, Cancer prevention by phytochemicals, Oncology Suppl. 1: 38-40. (2005).
N. Mendoza and E.M.E. Silva, Introduction to phytochemicals: secondary metabolites from plants with active principles for pharmacological importance, Phytochemicals: Source of antioxidants and role in disease prevention.(2018).
C.J. Dillard and J.B. German, Phytochemicals: nutraceuticals and human health, Journal of the Science of Food Agriculture 12: 1744-1756. (2000).
E. Nielsen, M.E.E. Temporiti, and R. Cella, Improvement of phytochemical production by plant cells and organ culture and by genetic engineering, Plant cell reports 10: 1199-1215. (2019).
L. Herrera-Estrella, A. Depicker, M. Van Montagu, and J. Schell, Expression of chimaeric genes transferred into plant cells using a Ti-plasmidderived vector, Nature 5914: 209-213. (1983).
D.J. Yun, T. Hashimoto, and Y. Yamada, Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition, Proceedings of the National Academy of Sciences 24: 11799-11803. (1992).
K. Jouhikainen, L. Lindgren, T. Jokelainen, R. Hiltunen, T.H. Teeri, and K.-M. Oksman-Caldentey, Enhancement of scopolamine production in Hyoscyamus muticus L. hairy root cultures by genetic engineering, Planta 4: 545-551. (1999).
P. Rocha, O. Stenzel, A. Parr, N. Walton, P. Christou, B. Dräger, and M.J. Leech, Functional expression of tropinone reductase I (trI) and hyoscyamine6β-hydroxylase (h6h) from Hyoscyamus niger in Nicotiana tabacum, Plant Science 6: 905-913. (2002).
J. Laurila, I. Laakso, J. Valkonen, R. Hiltunen, nd E. Pehu, Formation of parental-type and novel glycoalkaloids in somatic hybrids between Solanum brevidens and S. tuberosum, Plant Science 2: 145-155. (1996).
Y.J. Zhang, R.Y. Gan, S. Li, Y. Zhou, A.N. Li, D.P. Xu, and H.B.J.M. Li, Antioxidant phytochemicals for the prevention and treatment of chronic diseases, Molecules 12: 21138-21156. (2015).
Y. Cetinkaya, P. Falk, and C.G. Mayhall, Vancomycin-resistant enterococci, Clinical microbiology reviews 4: 686-707. (2000).
M.A. Grusak, Phytochemicals in plants: genomicsassisted plant improvement for nutritional and health benefits, Current opinions in biotechnology 5: 508-511. (2002).
P. Lucca, R. Hurrell, and I. Potrykus, Genetic engineering approaches to improve the bioavailability and the level of iron in rice grains,
Theoretical and Applied Genetics 2-3: 392-397. (2001).
A.K. Jain and C.L. Nessler, Metabolic engineering of an alternative pathway for ascorbic acid biosynthesis in plants, Molecular Breeding 1: 73-78. (2000).
B.A. Behbahani, F.T. Yazdi, F. Shahidi, H. Noorbakhsh, A. Vasiee, and A. Alghooneh,Phytochemical analysis and antibacterial activities
extracts of mangrove leaf against the growth of some pathogenic bacteria, Microbial pathogenesis: 225-232. (2018).
P.M. Tibbles and J.S. Edelsberg, Hyperbaric-oxygen therapy, New England Journal of Medicine 25: 1642-1648. (1996).
I.C.V. Windsant, N.C. de Wit, J.T. Sertorio, E.A. Beckers, J.E. Tanus-Santos, M.J. Jacobs, and W.A. Buurman, Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study, Critical care 3: 1-11. (2012).
A. McCutcheon, T. Roberts, E. Gibbons, S. Ellis, L. Babiuk, R. Hancock, and G. Towers, Antiviral screening of British Columbian medicinal plants, Journal of Ethnopharmacology 2: 101-110. (1995).
R.V. Chikhale, S.K. Sinha, R.B. Patil, S.K. Prasad, A. Shakya, N. Gurav, R. Prasad, S.R. Dhaswadikar, M. Wanjari, and S.S. Gurav, In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19, Journal of Biomolecular Structure Dynamics: 1-15. (2020).
S.Y. Li, C. Chen, H.Q. Zhang, H.Y. Guo, H. Wang, L. Wang, X. Zhang, S.N. Hua, J. Yu, and P.G. Xiao, Identification of natural compounds with antiviral activities against SARS-associated coronavirus, Antiviral research 1: 18-23. (2005).
C.W. Lin, F.J. Tsai, C.H. Tsai, C.C. Lai, L. Wan, T.Y. Ho, C.C. Hsieh, and P.D.L. Chao, AntiSARS coronavirus 3C-like protease effects of
Isatis indigotica root and plant-derived phenolic compounds, Antiviral research 1: 36-42. (2005).
Q.Y. Yang, X.Y. Tian, and W.S. Fang, Bioactive coumarins from Boenninghausenia sessilicarpa, Journal of Asian natural products research 1: 59-65. (2007).
C.Y. Wu, J.T. Jan, S.H. Ma, C.J. Kuo, H.F. Juan, Y.S.E. Cheng, H.H. Hsu, H.C. Huang, D. Wu, and A. Brik, Small molecules targeting severe
acute respiratory syndrome human coronavirus, Proceedings of the National Academy of Sciences 27: 10012-10017. (2004).
C.C. Wen, L.F. Shyur, J.T. Jan, P.H. Liang, C.J. Kuo, P. Arulselvan, J.B. Wu, S.C. Kuo, and N.S. Yang, Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication, Journal of traditional and complementary medicine 1: 41-50. (2011).
F. Chen, K. Chan, Y. Jiang, R. Kao, H. Lu, K. Fan, V. Cheng, W. Tsui, I. Hung, and T. Lee, In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds, Journal of clinical virology 1: 69-75. (2004).
I. Thabti, Q. Albert, S. Philippot, F. Dupire, B. Westerhuis, S. Fontanay, A. Risler, T. Kassab, W. Elfalleh, and A.J.M. Aferchichi, Advances on antiviral activity of Morus spp. plant extracts: Human coronavirus and virus-related respiratory tract infections in the spotlight, Molecules 8: 1876. (2020).
Y.C. Shen, L.T. Wang, A.T. Khalil, L.C. Chiang, and P.W. Cheng, Bioactive pyranoxanthones from the roots of Calophyllum blancoi, Chemical pharmaceutical bulletin 2: 244-247. (2005).
M. Michaelis, H.W. Doerr, and J. Cinatl Jr, Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses, Phytomedicine 5: 384-386. (2011).
J.Y. Park, H.J. Yuk, H.W. Ryu, S.H. Lim, K.S. Kim, K.H. Park, Y.B. Ryu, and W.S. Lee, Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors, Journal of enzyme inhibition and medicinal chemistry 1: 504-512. (2017).
J.R. Weng, C.S. Lin, H.C. Lai, Y.P. Lin, C.Y. Wang, Y.C. Tsai, K.C. Wu, S.H. Huang, and C.W. Lin, Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63, Virus Research:
(2019).
D.E. Kim, J.S. Min, M.S. Jang, J.Y. Lee, Y.S. Shin, C.M. Park, J.H. Song, H.R. Kim, S. Kim, and Y.-H.J.B. Jin, Natural bis-benzylisoquinoline alkaloidstetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC5 human lung cells, Biomolecules 11: 696. (2019).
C. Müller, F.W. Schulte, K. Lange-Grünweller, W. Obermann, R. Madhugiri, S. Pleschka, J. Ziebuhr, R.K. Hartmann, and A. Grünweller, Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona-and picornaviruses, Antiviral research: 123-129. (2018).
C.N. Chen, C.P. Lin, K.-K. Huang, W.-C. Chen, H.-P. Hsieh, P.-H. Liang, and J.T.-A. Hsu, Inhibition of SARS-CoV 3C-like protease activity by
theaflavin-3, 3’-digallate (TF3), Evidence-Based Complementary Alternative Medicine 2: 209-215. (2005).
Downloads
Published
How to Cite
Issue
Section
License
Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.
